Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs M&T Bank Corporation (MTB) Price & Performance

AstraZeneca plcTrade
M&T Bank CorporationTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs M&T Bank Corporation — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: AstraZeneca plc is far larger — about 6.8× M&T Bank Corporation's market cap, and M&T Bank Corporation pays the higher dividend (2.38%). Which is the better fit depends on your goals.

AZNMTB
Market Cap
$248.14B$36.42B
Sector
HealthFinancials
52-Week High
$209.48$254.04
52-Week Low
$147.06$178.63
Enterprise Value
$275.41B
Dividend Yield
2.01%2.38%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About M&T Bank Corporation

M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.

Read more on MTB